126 related articles for article (PubMed ID: 37926942)
41. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
[TBL] [Abstract][Full Text] [Related]
42. Oral Fluoroquinolone Use and the Risk of Acute Liver Injury: A Nationwide Cohort Study.
Nibell O; Svanström H; Inghammar M
Clin Infect Dis; 2022 Jul; 74(12):2152-2158. PubMed ID: 34537834
[TBL] [Abstract][Full Text] [Related]
43. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes.
Edraki M; Nobakhti M; Naghshzan A; Amoozgar H; Amirghofran A; Ghasemzadeh B; Nirooie E; Mehdizadegan N; Mohammadi H; Keshavarz K
BMC Cardiovasc Disord; 2022 Jul; 22(1):315. PubMed ID: 35840901
[TBL] [Abstract][Full Text] [Related]
44. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality.
Witberg G; Codner P; Landes U; Schwartzenberg S; Barbanti M; Valvo R; De Backer O; Ooms JF; Islas F; Marroquin L; Sedaghat A; Sugiura A; Masiero G; Werner P; Armario X; Fiorina C; Arzamendi D; Santos-Martinez S; Fernández-Vázquez F; Baz JA; Steblovnik K; Mauri V; Adam M; Merdler I; Hein M; Ruile P; Grasso C; Branca L; Estévez-Loureiro R; Benito-González T; Amat-Santos IJ; Mylotte D; Andreas M; Bunc M; Tarantini G; Sinning JM; Nombela-Franco L; Søndergaard L; Van Mieghem NM; Finkelstein A; Kornowski R
JACC Cardiovasc Interv; 2021 Jun; 14(11):1181-1192. PubMed ID: 33992550
[TBL] [Abstract][Full Text] [Related]
45. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Cisterna R; Fresnadillo MJ; García-Rodríguez JA; Gobernado M; Martín R; Perea E; Picazo J
Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and Prognostic Implications of Moderate or Severe Mitral Regurgitation in Patients with Bicuspid Aortic Valve.
Butcher SC; Prevedello F; Fortuni F; Kong WKF; Singh GK; Ng ACT; Perry R; Poh KK; Almeida AG; González A; Shen M; Yeo TC; Shanks M; Popescu BA; Gay LG; Fijałkowski M; Liang M; Tay E; Ajmone Marsan N; Selvanayagam JB; Pinto F; Zamorano JL; Pibarot P; Evangelista A; Bax JJ; Delgado V
J Am Soc Echocardiogr; 2023 Apr; 36(4):402-410. PubMed ID: 36332801
[TBL] [Abstract][Full Text] [Related]
47. Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study.
Alrwisan A; Antonelli PJ; Brumback BA; Wei YJ; Winterstein AG
Otol Neurotol; 2018 Sep; 39(8):957-963. PubMed ID: 29965935
[TBL] [Abstract][Full Text] [Related]
48. Different antibiotic treatments for group A streptococcal pharyngitis.
Hedin K; Thorning S; van Driel ML
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD004406. PubMed ID: 37965935
[TBL] [Abstract][Full Text] [Related]
49. Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics.
Yagi T; Mannheimer B; Reutfors J; Ursing J; Giunta DH; Kieler H; Linder M
Br J Clin Pharmacol; 2023 Feb; 89(2):887-897. PubMed ID: 36098510
[TBL] [Abstract][Full Text] [Related]
50. Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.
Hsu SC; Chang SS; Lee MG; Lee SH; Tsai YW; Lin SC; Chen ST; Weng YC; Porta L; Wu JY; Lee CC
PLoS One; 2017; 12(9):e0183813. PubMed ID: 28873440
[TBL] [Abstract][Full Text] [Related]
51. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
[TBL] [Abstract][Full Text] [Related]
52. Comparative neurological safety of fluoroquinolones versus therapeutic alternatives.
Ellis DE; Hubbard RA; Willis AW; Zuppa AF; Zaoutis TE; Hennessy S
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):797-805. PubMed ID: 33655544
[TBL] [Abstract][Full Text] [Related]
53. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
Vinereanu D; Wang A; Mulder H; Lopes RD; Jansky P; Lewis BS; Gersh BJ; Avezum A; Hanna M; Held C; Wallentin L; Granger CB; Alexander JH
Heart; 2018 Aug; 104(15):1292-1299. PubMed ID: 29352007
[TBL] [Abstract][Full Text] [Related]
54. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.
Son N; Choi E; Chung SY; Han SY; Kim B
BMC Cardiovasc Disord; 2022 Feb; 22(1):44. PubMed ID: 35152888
[TBL] [Abstract][Full Text] [Related]
55. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
Breithardt G; Baumgartner H; Berkowitz SD; Hellkamp AS; Piccini JP; Lokhnygina Y; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Califf RM; Fox KA; Patel MR;
Heart; 2016 Jul; 102(13):1036-43. PubMed ID: 26888572
[TBL] [Abstract][Full Text] [Related]
56. Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation.
Kato N; Thaden JJ; Miranda WR; Scott CG; Sarano ME; Greason KL; Pellikka PA
ESC Heart Fail; 2021 Dec; 8(6):5482-5492. PubMed ID: 34652057
[TBL] [Abstract][Full Text] [Related]
57. Risk of acute kidney injury associated with the use of fluoroquinolones.
Bird ST; Etminan M; Brophy JM; Hartzema AG; Delaney JA
CMAJ; 2013 Jul; 185(10):E475-82. PubMed ID: 23734036
[TBL] [Abstract][Full Text] [Related]
58. Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.
Kim Y; Paik M; Khan C; Kim YJ; Kim E
Sci Rep; 2019 Dec; 9(1):20156. PubMed ID: 31882917
[TBL] [Abstract][Full Text] [Related]
59. Lack of association between fluoroquinolone and aortic aneurysm or dissection.
Huh K; Kang M; Jung J
Eur Heart J; 2023 Nov; 44(42):4476-4484. PubMed ID: 37724037
[TBL] [Abstract][Full Text] [Related]
60. Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation: Implications for Optimal Definition of Significant Aortic Regurgitation.
Vejpongsa P; Xu J; Quinones MA; Shah DJ; Zoghbi WA
JACC Cardiovasc Imaging; 2022 Oct; 15(10):1730-1741. PubMed ID: 35842362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
